TrialPloS one2014

The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health.

Roger J Bedimo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.